{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:53:05Z","timestamp":1791582785684,"version":"4.3.4"},"reference-count":74,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Genetics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tig.2026.06.003","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:17:51Z","timestamp":1783052271000},"page":"888-897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic suppressors as new therapeutic targets for Mendelian diseases"],"prefix":"10.1016","volume":"42","author":[{"given":"Claire","family":"Paltenghi-Peceva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"van Schie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erfan","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Friend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3991-518X","authenticated-orcid":false,"given":"Jolanda","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tig.2026.06.003_bb0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","article-title":"Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database","volume":"28","author":"Nguengang Wakap","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.tig.2026.06.003_bb0010","doi-asserted-by":"crossref","first-page":"D789","DOI":"10.1093\/nar\/gku1205","article-title":"OMIM.org: Online Mendelian Inheritance in Man (OMIM\u00ae), an online catalog of human genes and genetic disorders","volume":"43","author":"Amberger","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tig.2026.06.003_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(24)00056-1","article-title":"The landscape for rare diseases in 2024","volume":"12","author":"The Lancet Global Health","year":"2024","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.tig.2026.06.003_bb0020","first-page":"677","article-title":"Genetic disorders in children and young adults: a population study","volume":"42","author":"Baird","year":"1988","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tig.2026.06.003_bb0025","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.3390\/molecules25143145","article-title":"Second-generation pharmacological chaperones: beyond inhibitors","volume":"25","author":"Tran","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.tig.2026.06.003_bb0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00508-024-02368-8","article-title":"Gene therapy: principles, challenges and use in clinical practice","volume":"137","author":"Ay","year":"2025","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.tig.2026.06.003_bb0035","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.ymthe.2025.04.045","article-title":"Current clinical applications of AAV-mediated gene therapy","volume":"33","author":"Byrne","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tig.2026.06.003_bb0040","doi-asserted-by":"crossref","DOI":"10.1126\/science.aag0839","article-title":"Exploring genetic suppression interactions on a global scale","volume":"354","author":"van Leeuwen","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.tig.2026.06.003_bb0045","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20209828","article-title":"Systematic analysis of bypass suppression of essential genes","volume":"16","author":"van Leeuwen","year":"2020","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.tig.2026.06.003_bb0050","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s41467-019-08928-1","article-title":"Systematic analysis reveals the prevalence and principles of bypassable gene essentiality","volume":"10","author":"Li","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tig.2026.06.003_bb0055","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2015.10.069","article-title":"Gene essentiality is a quantitative property linked to cellular evolvability","volume":"163","author":"Liu","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.tig.2026.06.003_bb0060","series-title":"WormBook: The Online Review of Caenorhabditis elegans Biology","first-page":"1","article-title":"Genetic suppression","author":"Hodgkin","year":"2005"},{"key":"10.1016\/j.tig.2026.06.003_bb0065","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/ng.2714","article-title":"A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome","volume":"45","author":"Buchovecky","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tig.2026.06.003_bb0070","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nrg751","article-title":"The art and design of genetic screens: Drosophila melanogaster","volume":"3","author":"St Johnston","year":"2002","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tig.2026.06.003_bb0075","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.tig.2011.05.007","article-title":"Molecular mechanisms of epistasis within and between genes","volume":"27","author":"Lehner","year":"2011","journal-title":"Trends Genet."},{"key":"10.1016\/j.tig.2026.06.003_bb0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13073-023-01232-0","article-title":"Global analysis of suppressor mutations that rescue human genetic defects","volume":"15","author":"\u00dcnl\u00fc","year":"2023","journal-title":"Genome Med."},{"key":"10.1016\/j.tig.2026.06.003_bb0085","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ajh.23232","article-title":"Genetic modifiers of sickle cell disease","volume":"87","author":"Steinberg","year":"2012","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.tig.2026.06.003_bb0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3233\/CH-189012","article-title":"Inflammation in sickle cell disease","volume":"68","author":"Conran","year":"2018","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"10.1016\/j.tig.2026.06.003_bb0095","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1002\/ppul.24129","article-title":"Inflammation in cystic fibrosis: an update","volume":"53","author":"Roesch","year":"2018","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.tig.2026.06.003_bb0100","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1073\/pnas.0711566105","article-title":"Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia","volume":"105","author":"Uda","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tig.2026.06.003_bb0105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2029392","article-title":"Post-transcriptional genetic silencing of BCL11A to treat sickle cell disease","volume":"384","author":"Esrick","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tig.2026.06.003_bb0110","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and beta-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tig.2026.06.003_bb0115","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1073\/pnas.0804799105","article-title":"DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease","volume":"105","author":"Lettre","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tig.2026.06.003_bb0120","doi-asserted-by":"crossref","first-page":"E682","DOI":"10.1002\/humu.21002","article-title":"The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene","volume":"30","author":"Abifadel","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.tig.2026.06.003_bb0125","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021754","article-title":"Loss-of-function mutation of PCSK9 as a protective factor in the clinical expression of familial hypercholesterolemia: a case report","volume":"99","author":"Bayona","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.tig.2026.06.003_bb0130","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa2019910","article-title":"Evolocumab in pediatric heterozygous familial hypercholesterolemia","volume":"383","author":"Santos","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tig.2026.06.003_bb0135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ana.23899","article-title":"Inhibiting glycogen synthesis prevents Lafora disease in a mouse model","volume":"74","author":"Pederson","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tig.2026.06.003_bb0140","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/hmg\/ddu024","article-title":"Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease","volume":"23","author":"Duran","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tig.2026.06.003_bb0145","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s13311-021-01040-7","article-title":"Targeting Gys1 with AAV-SaCas9 decreases pathogenic polyglucosan bodies and neuroinflammation in adult polyglucosan body and Lafora disease mouse models","volume":"18","author":"Gumusgoz","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.tig.2026.06.003_bb0150","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/cpt.3470","article-title":"First-in-human evaluation of safety, pharmacokinetics and muscle glycogen lowering of a novel glycogen synthase 1 inhibitor for the treatment of Pompe disease","volume":"116","author":"Ullman","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tig.2026.06.003_bb0155","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-025-08942-y","article-title":"PLA2G15 is a BMP hydrolase and its targeting ameliorates lysosomal disease","volume":"642","author":"Nyame","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.tig.2026.06.003_bb0160","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/s41586-025-09373-5","article-title":"Genetic suppression features ABHD18 as a Barth syndrome therapeutic target","volume":"645","author":"Masud","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.tig.2026.06.003_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110237","article-title":"ABHD18 degrades cardiolipin by stepwise hydrolysis of fatty acids","volume":"301","author":"Ren","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tig.2026.06.003_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001935","article-title":"The genomic landscape of compensatory evolution","volume":"12","author":"Szamecz","year":"2014","journal-title":"PLoS Biol."},{"key":"10.1016\/j.tig.2026.06.003_bb0175","doi-asserted-by":"crossref","DOI":"10.1093\/g3journal\/jkaf047","article-title":"Genetic suppression interactions are highly conserved across genetically diverse yeast isolates","volume":"15","author":"Paltenghi","year":"2025","journal-title":"G3 (Bethesda)"},{"key":"10.1016\/j.tig.2026.06.003_bb0180","doi-asserted-by":"crossref","DOI":"10.15252\/msb.202010138","article-title":"Natural variants suppress mutations in hundreds of essential genes","volume":"17","author":"Parts","year":"2021","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.tig.2026.06.003_bb0185","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00439-020-02199-3","article-title":"The Human Gene Mutation Database (HGMD\u00ae): optimizing its use in a clinical diagnostic or research setting","volume":"139","author":"Stenson","year":"2020","journal-title":"Hum. Genet."},{"key":"10.1016\/j.tig.2026.06.003_bb0190","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1101\/gr.258400.119","article-title":"Suppressor mutations in Mecp2-null mice implicate the DNA damage response in Rett syndrome pathology","volume":"30","author":"Enikanolaiye","year":"2020","journal-title":"Genome Res."},{"key":"10.1016\/j.tig.2026.06.003_bb0195","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nbt.3514","article-title":"Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseases","volume":"34","author":"Chen","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tig.2026.06.003_bb0200","doi-asserted-by":"crossref","first-page":"9623","DOI":"10.1038\/s41467-025-61698-x","article-title":"Exploring penetrance of clinically relevant variants in over 800,000 humans from the Genome Aggregation Database","volume":"16","author":"Gudmundsson","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tig.2026.06.003_bb0205","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/gim.2017.50","article-title":"Assessment of the ExAC data set for the presence of individuals with pathogenic genotypes implicated in severe Mendelian pediatric disorders","volume":"19","author":"Tarailo-Graovac","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.tig.2026.06.003_bb0210","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41431-025-02009-2","article-title":"Unexpected genotypes associated with severe paediatric conditions identified in a healthy population cohort","volume":"34","author":"Bylstra","year":"2026","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.tig.2026.06.003_bb0215","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/cvr\/cvaa019","article-title":"MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes","volume":"117","author":"Lee","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tig.2026.06.003_bb0220","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41576-019-0139-x","article-title":"Somatic genetic rescue in Mendelian haematopoietic diseases","volume":"20","author":"Revy","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tig.2026.06.003_bb0225","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/bjh.15729","article-title":"Shwachman-Diamond syndrome with clonal interstitial deletion of the long arm of chromosome 20 in bone marrow: haematological features, prognosis and genomic instability","volume":"184","author":"Valli","year":"2019","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.tig.2026.06.003_bb0230","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.2012.09033.x","article-title":"Deletion of chromosome 20 in bone marrow of patients with Shwachman-Diamond syndrome, loss of the EIF6 gene and benign prognosis","volume":"157","author":"Pressato","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.tig.2026.06.003_bb0235","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41467-021-21588-4","article-title":"Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome","volume":"12","author":"Kennedy","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tig.2026.06.003_bb0240","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1038\/s41467-021-24999-5","article-title":"Somatic genetic rescue of a germline ribosome assembly defect","volume":"12","author":"Tan","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tig.2026.06.003_bb0245","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood.2018893404","article-title":"EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome","volume":"134","author":"Tan","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.tig.2026.06.003_bb0250","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ng1994","article-title":"The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast","volume":"39","author":"Menne","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tig.2026.06.003_bb0255","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nsmb.3112","article-title":"Mechanism of eIF6 release from the nascent 60S ribosomal subunit","volume":"22","author":"Weis","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.tig.2026.06.003_bb0260","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s13311-023-01434-9","article-title":"Gys1 antisense therapy prevents disease-driving aggregates and epileptiform discharges in a Lafora disease mouse model","volume":"20","author":"Donohue","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.tig.2026.06.003_bb0265","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41596-021-00653-8","article-title":"Pooled genetic perturbation screens with image-based phenotypes","volume":"17","author":"Feldman","year":"2022","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.tig.2026.06.003_bb0270","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.cell.2016.11.038","article-title":"Perturb-seq: dissecting molecular circuits with scalable single-cell RNA profiling of pooled genetic screens","volume":"167","author":"Dixit","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.tig.2026.06.003_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/7651_2021_457","article-title":"Dissecting molecular phenotypes through FACS-based pooled CRISPR screens","volume":"2520","author":"Genolet","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tig.2026.06.003_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.896749","article-title":"Case report: heterozygous germline variant in EIF6 additional to biallelic SBDS pathogenic variants in a patient with ribosomopathy Shwachman-Diamond syndrome","volume":"13","author":"Taha","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.tig.2026.06.003_bb0285","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1146\/annurev-genom-083117-021329","article-title":"Cystic fibrosis disease modifiers: complex genetics defines the phenotypic diversity in a monogenic disease","volume":"19","author":"O\u2019Neal","year":"2018","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.tig.2026.06.003_bb0290","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aar2631","article-title":"Mechanisms of KCNQ1 channel dysfunction in long QT syndrome involving voltage sensor domain mutations","volume":"4","author":"Huang","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tig.2026.06.003_bb0295","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tig.2026.06.003_bb0300","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.015773","article-title":"An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice","volume":"296","author":"Nitschke","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tig.2026.06.003_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105173","article-title":"Suppression of glycogen synthesis as a treatment for Lafora disease: establishing the window of opportunity","volume":"147","author":"Varea","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tig.2026.06.003_bb0310","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/nm.2901","article-title":"EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans","volume":"18","author":"Van Hoecke","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.tig.2026.06.003_bb0315","article-title":"Decreased signalling of EphA4 improves functional performance and motor neuron survival in the SOD1(G93A) ALS mouse model","volume":"8","author":"Zhao","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tig.2026.06.003_bb0320","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50615-0","article-title":"Reducing EphA4 before disease onset does not affect survival in a mouse model of amyotrophic lateral sclerosis","volume":"9","author":"Rue","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tig.2026.06.003_bb0325","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72723-y","article-title":"Inducible EphA4 knockout causes motor deficits in young mice and is not protective in the SOD1(G93A) mouse model of ALS","volume":"10","author":"Dominguez","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tig.2026.06.003_bb0330","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nbd.2018.03.002","article-title":"Antisense-mediated reduction of EphA4 in the adult CNS does not improve the function of mice with amyotrophic lateral sclerosis","volume":"114","author":"Ling","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tig.2026.06.003_bb0335","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ng.873","article-title":"Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility","volume":"43","author":"Evans","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tig.2026.06.003_bb0340","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1074\/jbc.M113.529487","article-title":"Deletion of the cardiolipin-specific phospholipase Cld1 rescues growth and life span defects in the tafazzin mutant: implications for Barth syndrome","volume":"289","author":"Ye","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tig.2026.06.003_bb0345","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/onc.2016.386","article-title":"EGFR-Stat3 signalling in nerve glial cells modifies neurofibroma initiation","volume":"36","author":"Wu","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.tig.2026.06.003_bb0350","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajhg.2017.05.012","article-title":"A genetic variant ameliorates beta-thalassemia severity by epigenetic-mediated elevation of human fetal hemoglobin expression","volume":"101","author":"Chen","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tig.2026.06.003_bb0355","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/s41591-023-02318-3","article-title":"Resilience to autosomal dominant Alzheimer\u2019s disease in a Reelin-COLBOS heterozygous man","volume":"29","author":"Lopera","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.tig.2026.06.003_bb0360","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1126\/science.1255648","article-title":"Translational genomics. Clues from the resilient","volume":"344","author":"Friend","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.tig.2026.06.003_bb0365","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/s41586-026-10176-5","article-title":"Genome modelling and design across all domains of life with Evo 2","volume":"652","author":"Brixi","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.tig.2026.06.003_bb0370","doi-asserted-by":"crossref","DOI":"10.1126\/science.adg7492","article-title":"Accurate proteome-wide missense variant effect prediction with AlphaMissense","volume":"381","author":"Cheng","year":"2023","journal-title":"Science"}],"container-title":["Trends in Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168952526001460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168952526001460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:08:37Z","timestamp":1791580117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168952526001460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":74,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0168952526001460"],"URL":"https:\/\/doi.org\/10.1016\/j.tig.2026.06.003","relation":{},"ISSN":["0168-9525"],"issn-type":[{"value":"0168-9525","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic suppressors as new therapeutic targets for Mendelian diseases","name":"articletitle","label":"Article Title"},{"value":"Trends in Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tig.2026.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}